Eczema cream recalled over risk of 'life-threatening' staph infection

A Wisconsin company is recalling a cream used to treat eczema due to contamination with Staphylococcus aureus. The recall was announced by the Food and Drug Administration on Tuesday. The contaminated product is Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, sold under the brand name MG217 by Pharmacal.